Ads
related to: Skyrizi- Before & After Photos
Access the Patient Photo Library.
See Before/After Photos.
- Otezla® Resource Center
Explore Educational Materials.
View Videos, Get FAQs, & More.
- Safety & Efficacy Data
Get Otezla ® Clinical Study Data.
See The Safety Profile.
- Safety Information
Get Important Safety
Information About Otezla®
- Request A Rep
Order Otezla Starter Kit And
Learn More About the Data.
- About Otezla® Therapy
Learn About Clinical Trial Data
And Get Safety Information
- Before & After Photos
Search results
Pharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New Indication
Zacks via Yahoo Finance· 1 year agoThis week, Merck MRK offered to buy Imago Biosciences IMGO, which is developing drugs to treat bone...
AbbVie (ABBV) Provides Clinical Updates on Inflammatory Drugs
Zacks via Yahoo Finance· 1 year agoAbbVie ABBV announced multiple clinical updates pertaining to clinical studies evaluating its...
AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion
Reuters via AOL· 3 months ago(Reuters) -AbbVie on Friday raised its 2027 forecast for sales of its immunology drugs Skyrizi and...
Will AbbVie's (ABBV) New Drugs Make Up for Low Humira Sales?
Zacks via Yahoo Finance· 10 months agoIn its Q2 earnings results, AbbVie's (ABBV) Skyrizi and Rinvoq sales are expected to have made up...
AbbVie (ABBV) Q4 2022 Earnings Call Transcript
Motley Fool· 1 year agoImage source: The Motley Fool. AbbVie (NYSE: ABBV) Q4 2022 Earnings Call Feb 09, 2023, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
AbbVie Psoriatic Arthritis Drug Shows Long-term Effect On Skin, Joint Symptoms
Benzinga via Yahoo Finance· 2 years agoAbbVie Inc (NASDAQ: ABBV) announced new, long-term data analyses of KEEPsAKE 1 and 2, Phase 3 trials...
AbbVie (ABBV) Beats Q4 Earnings Estimates, Misses on Sales
Zacks via Yahoo Finance· 1 year agoAbbVie Inc. ABBV reported adjusted earnings of $3.60 per share for the fourth quarter of 2022,...
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Zacks via Yahoo Finance· 2 weeks agoAbbVie Inc. ABBV reported adjusted earnings of $2.31 per share for first-quarter 2024, beating the...
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 3 weeks agoAbbVie ABBV will report first-quarter 2024 results on Apr 26, before market open. In the last...
Can AbbVie (ABBV) Protect Revenues After Humira Patent Loss?
Zacks via Yahoo Finance· 9 months agoAbbVie’s ABBV key blockbuster immunology medicine, Humira lost patent protection in the United...
Ads
related to: Skyrizi